Skip to main content
SpringerLink
Log in

Deep learning in molecular biology marker recognition of patients with acute myeloid leukemia

  • Published:
The Journal of Supercomputing Aims and scope Submit manuscript

Abstract

In this study, the deep belief network (DBN) algorithm was used to identify the Wilm’s tumor 1 (WT1) gene expression levels, and then, the role of WT1 expression in the classification of acute myeloid leukemia (AML) was explored. 121 AML patients diagnosed in the hospital from 2017.10 to 2019.10 were selected as the research subjects and set as the AML group. Another 9 non-leukemia patients were selected as the control group. The expression levels of WT1 in the two groups were compared, and DBN was used to classify the patients based on the WT1 expression levels. The real-time quantitative PCR was used to detect the abnormalities of FLT3, PML-RAR, and other molecular markers at different WT1 expression levels. The results showed that the expression of WT1 in AML patients was significantly higher than that in non-leukemia patients. The expression of WT1 in patients of M3 type was the highest, and that was the lowest in patients of the M5 type. The accuracy, precision, recall, and F1 indexes for WT1 expression identification using deep belief network were 94.06%, 93.82%, 93.59%, and 93.63%, respectively. In conclusion, deep learning technology is very sensitive in identifying the molecular biology markers in AML patients, which provides a reference for efficient and intelligent disease diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

Similar content being viewed by others

References

  1. Dohner H, Weisdorf DJ, Bloomfield CD (2015) Acute myeloid leukemia. N Engl J Med 373(12):1136–1152

    Article  Google Scholar 

  2. De Kouchkovsky I, Abdul-Hay M (2016) Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer 6(7):e441

    Article  Google Scholar 

  3. Prada-Arismendy J, Arroyave JC, Rothlisberger S (2017) Molecular biomarkers in acute myeloid leukemia. Blood Rev 31(1):63–76

    Article  Google Scholar 

  4. Bullinger L, Dohner K, Dohner H (2017) Genomics of acute myeloid leukemia diagnosis and pathways. J Clin Oncol 35(9):934–946

    Article  Google Scholar 

  5. Chapuis AG, Egan DN, Bar M et al (2019) T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant. Nat Med 25(7):1064–1072

    Article  Google Scholar 

  6. Du D, Zhu L, Wang Y et al (2019) Expression of WT1 gene and its prognostic value in patients with acute myeloid leukemia. Zhejiang Da Xue Xue Bao Yi Xue Ban 48(1):50–57

    Google Scholar 

  7. Niktoreh N, Walter C, Zimmermann M et al (2019) Mutated WT1, FLT3-ITD, and NUP98-NSD1 fusion in various combinations define a poor prognostic group in pediatric acute myeloid leukemia. J Oncol 2019:1609128

    Article  Google Scholar 

  8. Pan C, Schoppe O, Parra-Damas A et al (2019) Deep Learning Reveals Cancer Metastasis and Therapeutic Antibody Targeting in the Entire Body. Cell 179(7):1661–1676

    Article  Google Scholar 

  9. Coudray N, Ocampo PS, Sakellaropoulos T et al (2018) Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning. Nat Med 24(10):1559–1567

    Article  Google Scholar 

  10. Zuo Y, Cheng Y, Zhang L et al (2019) Wilms’ tumor 1 mRNA expression: a good tool for differentiating between myelodysplastic syndrome and aplastic anemia in children? Hematology 24(1):480–486

    Article  Google Scholar 

  11. Pandey S, Moazam M, Ghimirey N et al (2019) WT1 regulates cyclin A1 expression in K562 cells. Oncol Rep 42(5):2016–2028

    Google Scholar 

  12. Han Z, Wei B, Zheng Y et al (2017) Breast cancer multi-classification from histopathological images with structured deep learning model. Sci Rep 7(1):4172

    Article  Google Scholar 

  13. Suguna E, Farhana R, Kanimozhi E et al (2018) Acute myeloid leukemia: diagnosis and management based on current molecular genetics approach. Cardiovasc Hematol Disord Drug Targets 18(3):199–207

    Article  Google Scholar 

  14. Smolander J, Dehmer M, Emmert-Streib F (2019) Comparing deep belief networks with support vector machines for classifying gene expression data from complex disorders. FEBS Open Bio 9(7):1232–1248

    Article  Google Scholar 

  15. Yang JL, Zhao JJ, Qiang Y et al (2016) Classification of benign and malignant pulmonary nodules based on deep belief network. Sci Rep 16(032):69–74

    Google Scholar 

  16. Li ZC, Shi XY, Yu L et al (2019) Inhibition classification of CYP450 2C9 based on deep belief network. Sci Rep 36(02):195–199

    Google Scholar 

  17. Cancer Genome Atlas Research N, Ley TJ, Miller C et al (2013) Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 368(22):2059–2074

    Article  Google Scholar 

  18. Zhang X, Yang C, Peng X, Chen X, Feng Y (2017) Acute WT1-positive promyelocytic leukemia with hypogranular variant morphology, bcr-3 isoform of PML-RARα and Flt3-ITD mutation: a rare case report. Sao Paulo Med J. 135(2):179–184

    Article  Google Scholar 

  19. Papaemmanuil E, Gerstung M, Bullinger L et al (2016) Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med 374(23):2209–2221

    Article  Google Scholar 

  20. Huang HJ, Li B, Qin TJ, Xu ZF, Hu NB, Pan LJ, Qu SQ, Liu D, Zhang YD, Xiao ZJ (2020) Molecular features and prognostic value of RAS mutations in patients with myelodysplastic syndromes. Zhonghua Xue Ye Xue Za Zhi 41(9):723–730

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, The Affiliated People’s Hospital of Ningbo University, Ningbo, 315040, Zhejiang,, China

    Lieguang Chen, Ying Lu, Renzhi Pei, Pisheng Zhang, Xuhui Liu, Xiaohong Du, Dong Chen, Junjie Cao, Shuangyue Li & Xianxu Zhuang

Authors
  1. Lieguang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ying Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Renzhi Pei
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pisheng Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xuhui Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiaohong Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dong Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Junjie Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shuangyue Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Xianxu Zhuang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lieguang Chen.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, L., Lu, Y., Pei, R. et al. Deep learning in molecular biology marker recognition of patients with acute myeloid leukemia. J Supercomput 78, 11283–11297 (2022). https://doi.org/10.1007/s11227-021-04104-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11227-021-04104-9

Keywords

Search

Navigation